News Sentiment

4503 sentiment intelligence

Astellas Pharma Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 51 Balanced news tone 29 relevant articles
Exchange JPX Japan
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 2142.00 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

88/100 classification confidence.

Company focus 29

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend inactive

-0.5% over one week, +0.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

FDA’s PADCEV Keytruda Approval for All MIBC Patients Might Change The Case For Investing In Astellas Pharma (TSE:4503)

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 88/100 classification
One-week reaction -0.5% Price digesting
Trend fit Trend inactive 0.1% over four weeks
Fair value 26.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 22
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 29
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 7
Market source 6
PR Newswire 4
Seeking Alpha 2
Bloomberg.com 2
BioWorld News 2
Reuters 2
ad-hoc-news.de 1

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 2
Deals and strategy 2
Regulatory and legal 1
Analyst action 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-29 of 29